Poor Prognostic Factors in Long-Term Survivors of Resected Pancreatic Ductal Adenocarcinoma: An International, Multicenter Cohort Study.
Javed AA, Rompen IF, van Goor IWJM, Stoop TF, Andel P, Mahmud O, Fatimi AS, Habib JR, Mughal NA, Schouten T, Lafaro K, Burkhart RA, Burns WR, Santvoort HCV, Dulk MD, Daams F, Mieog JSD, Stommel MWJ, Patijn GA, Hingh I, Festen S, Nijkamp MW, Klaase JM, Lips DJ, Wijsman JH, Harst EV, Manusama E, Eijck CHJV, Koerkamp BG, Kazemier G, Busch OR, Molenaar IQ, Daamen LA, He J, Wolfgang CL, Besselink MG; Dutch Pancreatic Cancer Group and the PANC-PALS Consortium.
Javed AA, et al.
Ann Surg. 2024 Sep 17. doi: 10.1097/SLA.0000000000006539. Online ahead of print.
Ann Surg. 2024.
PMID: 39286904